Norges Bank Zentalis Pharmaceuticals, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.09 - $16.13 $292,545 - $1.15 Million	71,527 New	71,527 $292,000
Q4 2023 Feb 09, 2024	BUY	$9.84 - $20.13 $1.62 Million - $3.31 Million	164,342 New	164,342 $2.49 Million
Q3 2023 Nov 13, 2024	BUY	$19.63 - $28.29 $3.23 Million - $4.65 Million	164,342 New	164,342 $3.3 Million
Q3 2023 Nov 13, 2023	SELL	$19.63 - $28.29 $4.55 Million - $6.56 Million	-231,988 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$17.41 - $30.05 $1.68 Million - $2.89 Million	96,215 Added 134.52%	167,742 $4.73 Million
Q2 2023 Aug 14, 2023	SELL	$17.41 - $30.05 $5.78 Million - $9.98 Million	-332,044 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$16.14 - $24.94 $5.45 Million - $8.42 Million	337,642 New	337,642 $5.81 Million
Q4 2022 Feb 14, 2023	BUY	$18.07 - $25.6 $4.19 Million - $5.94 Million	231,988 New	231,988 $4.67 Million
Q3 2022 Nov 13, 2023	BUY	$20.23 - $31.73 $4.69 Million - $7.36 Million	231,988 New	231,988 $5.02 Million
Q2 2022 Aug 14, 2023	BUY	$17.91 - $52.25 $5.95 Million - $17.3 Million	332,044 New	332,044 $9.33 Million
Q1 2022 May 12, 2023	SELL	$41.58 - $80.89 $5.71 Million - $11.1 Million	-137,238 Reduced 59.16%	94,750 $4.37 Million
Q1 2022 May 09, 2022	SELL	$41.58 - $80.89 $2.24 Million - $4.35 Million	-53,783 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$66.92 - $84.79 $3.6 Million - $4.56 Million	53,783 New	53,783 $4.52 Million
Q3 2021 Nov 14, 2022	BUY	$46.83 - $73.5 $2.52 Million - $3.95 Million	53,783 New	53,783 $3.58 Million
Q3 2021 Nov 05, 2021	SELL	$46.83 - $73.5 $1.87 Million - $2.93 Million	-39,906 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$37.41 - $62.25 $1.49 Million - $2.48 Million	39,906 New	39,906 $2.12 Million
Q2 2021 Aug 10, 2021	SELL	$37.41 - $62.25 $1.08 Million - $1.8 Million	-28,926 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$35.69 - $52.72 $1.03 Million - $1.52 Million	28,926 New	28,926 $1.26 Million
Q1 2021 May 07, 2021	SELL	$35.69 - $52.72 $351,332 - $518,975	-9,844 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$31.71 - $57.97 $312,153 - $570,656	9,844 New	9,844 $511,000

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

Matrix Capital Management Company, LP Waltham, MA

14M
Shares

$41.7 Million
2.45% of portfolio
Eventide Asset Management, LLC Boston, MA

8.55M
Shares

$25.6 Million
0.55% of portfolio
Black Rock Inc. New York, NY

4.82M
Shares

$14.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.61M
Shares

$13.8 Million
0.0% of portfolio
Decheng Capital LLC Menlo Park, CA

3.11M
Shares

$9.29 Million
2.71% of portfolio

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $170M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account